Intellia Therapeutics (NTLA) Operating Leases (2019 - 2026)
Intellia Therapeutics (NTLA) recorded Operating Leases of $50.07 million in Q2 2026, down 33.8% from $75.6 million a year earlier and down 18.5% from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Intellia Therapeutics reported Operating Leases of $66.85 million, down 64.8% from FY2024.
- Annual Operating Leases has a five-year compound annual growth rate of 14.7% (FY2020 to FY2025).
- Across earlier years, Operating Leases came in at $189.95 million in FY2024 (+96.3%), $96.75 million in FY2023 (-15.1%), $114.02 million in FY2022 (+75.7%) and $64.91 million in FY2021 (+93.1%).
- The Q2 2026 figure is the lowest quarterly Operating Leases since Q4 2020.
- On a year-over-year basis, Operating Leases has declined for six consecutive quarters, with an average decline of 10.6% over the last eight quarters.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 320.5% in Q3 2021, against a decline of 64.8% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $61.4 million (Q1 2026), $66.85 million (Q4 2025) and $70.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Intellia Therapeutics | 1.60 Bn | 1.60 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.07 Mn |
| Mar 31, 2026 | 61.40 Mn |
| Dec 31, 2025 | 66.85 Mn |
| Sep 30, 2025 | 70.59 Mn |
| Jun 30, 2025 | 75.60 Mn |
| Mar 31, 2025 | 80.49 Mn |
| Dec 31, 2024 | 189.95 Mn |
| Sep 30, 2024 | 82.45 Mn |
| Jun 30, 2024 | 87.33 Mn |
| Mar 31, 2024 | 92.10 Mn |
| Dec 31, 2023 | 96.75 Mn |
| Sep 30, 2023 | 101.26 Mn |
| Jun 30, 2023 | 105.58 Mn |
| Mar 31, 2023 | 109.80 Mn |
| Dec 31, 2022 | 114.02 Mn |
| Sep 30, 2022 | 84.10 Mn |
| Jun 30, 2022 | 60.00 Mn |
| Mar 31, 2022 | 62.48 Mn |
| Dec 31, 2021 | 64.91 Mn |
| Sep 30, 2021 | 67.27 Mn |
API Access
Intellia Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();